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Abstract 
Leishmaniasis is a protozoal infection transmitted 
by a sandfly vector. In Germany, leishmaniasis of 
the mucous membranes is a rare condition and 
usually due to extension of local skin disease into 
the mucosal tissue via direct extension, 
bloodstream or lymphatics. We report a case of 
endonasal leishmaniasis in a female German 
resident who presented in a university hospital 
with nasal obstruction. Histology of the left nasal 
septum biopsy was suggestive of leishmaniasis. 
The molecular detection of DNA was positive for 
leishmania infantum. The patient was successfully 
treated as a case of mucocutaneous leishmaniasis 
receiving liposomal amphotericin follow up visits 
showed significant improvement with no 
recurrence. 
Introduction     
Leishmaniasis is a protozoal infection transmitted 
by a sandfly vector. According to the World Health 
Organization (WHO), mucocutaneous 
leishmaniasis (MCL) is endemic in Central and 
South America. Almost 90% of MCL cases occur in 
Bolivia, Brazil and Peru [1]. In Germany 
leishmaniasis of the mucous membranes is a rare 
condition and usually due to extension of local skin 
disease into the mucosal tissue via direct 
extension, bloodstream or lymphatics. Because of 
the chronic local destruction of facial structures, 
MCL may deface the patient if not recognized and 
adequately treated [2,3]. 
Patient and observation     
A 66-year-old German woman presented in a 
university hospital with nasal obstruction. 
Clinically the patient showed nodular and 
ulcerative lesion at the nasal septum. Histology of 
the left nasal septum biopsy revealed necrosis, 
chronic inflammation and intracellular amastigote 
that was suggestive of leishmaniasis (Figure 1). 
The molecular-pathological detection of parasite 
DNA was positive for leishmania infantum. The 
medical history includes hypothyroidism and 
rheumatoid arthritis for which she was under 
continuous immunosuppressive treatment with 
methotrexate and anti-TNF-blocker (Humira®) 
several years ago. Moreover, she was treated for 
cutaneous leishmaniasis in the left elbow after a 
travel history in Mallorca five years ago (4 weeks, 
amphotericin B). The patient successfully 
retreated as a case of mucocutaneous 
leishmaniasis receiving at first liposomal 
amphotericin B for 2 weeks. Under the treatment 
showed the patient an increased level of 
creatinine, therefore, the therapy was changed to 
a phospholipid (Hexadecylphosphocholin = 
Miltefosin®) for 4 weeks with a side effect of 
vomiting. Follow up visits showed significant 
improvement with no recurrence. 
Discussion     
Mucocutaneous leishmaniasis is rarely diagnosed 
in Germany. The majority of the cases are seen in 
patients living in or visiting endemic regions [3]. 
The reviewed medical literature through the 
electronic database Pubmed showed that 
leishmaniasis was not notifiable in Germany until 
2000. Within 2 years 70 cases of leishmaniasis (43 
cutaneous or mucocutaneous/mucosal, 27 
visceral) were reported. The data were available 
for 58 patients (35 cutaneous or 
mucocutaneous/mucosal; 23 visceral). Harms et 
al. report of 35 patients with MCL or CL, 30 had a 
travel history to endemic areas and seventeen 
lesions were located in the face, including mouth 
and nose [4]. MCL developed as a consequence of 
cutaneous leishmaniasis. The literature review 
showed that the favorite sites for manifestations 
of this disease in the nose were the cartilaginous 
part of the nasal septum, the anterior portions of 
nasal fossa, the floor of the nose and the lower 
turbinate [5,6]. Patients with endonasal 
leishmaniasis complain nasal obstruction, epistaxis 
or rhinorrhea-impaired breathing as well as septal 
perforation. Misdiagnosis may lead to an 
unfavorable outcome [3,5,6]. Histologically, MCL 
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diseases and differentiation is only possible by the 
morphological features of the parasite [6,7]. In 
majority of studies, the gold standard method of 
diagnosis was a biopsy with the molecular 
detection of parasite DNA by polymerase chain 
reaction (PCR) [2,8,9]. The primary goals of 
therapy for leishmaniasis is to prevent the 
mortality and morbidity. The first line of treatment 
for MCL is the pentavalent antimony compounds, 
liposomal amphotericin B or standard 
amphotericin B while miltefosine is used as a 
second line of treatment [9,10]. 
Conclusion     
MCL can lead to serious sequela, however, early 
diagnosis can prevent complications. The aim of 
this study to raise the awareness among the 
otolaryngologist in European countries of 
leishmaniasis of the mucous membranes as a 
differential diagnosis of mucocutaneous lesions 
especially in patients with travel history to 
endemic areas. 
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Figure     
Figure 1: photomicrograph shows intracellular 
amastigote (hematoxylin-eosin stain) 
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Figure 1: photomicrograph shows intracellular amastigote (hematoxylin-eosin stain) 
 
